Riskpilot← Back to searchSign inGet full accessArtifex Sanat AB
ABActiveOrg 5567901722Södra Storgatan 23 Lgh 1401General medical practice activities · NACE 8621Est. 20093 employees
Revenue 2025
SEK 7M
+1% vs 2024
EBITDA margin
18.1%
+13% vs 2024
Equity ratio
44.7%
Financial strength
Net profit 2025
SEK 664K
+10% vs 2024
| Revenue | SEK 7M | +1% |
| EBITDA | SEK 1,3M | +13% |
| Net profit | SEK 664K | +10% |
| Total assets | SEK 2,2M | +3% |
| Equity | SEK 976K | +7% |
| Employees | 3 | — |
Legal name
Artifex Sanat AB
Org number
5567901722
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
1 oktober 2009
Share capital
SEK 100 000
Employees
3 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva medicinsk konsultverksamhet och forskning, kliniska studier samt handel med värdepappeer jämte därmed förenlig verksamhet.
Address
Södra Storgatan 23 Lgh 1401
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 5 446 | 6 830 | 7 133 | 6 945 | 7 033 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −67 | 801 | 1 420 | 1 132 | 1 275 |
| Depreciation & amort. | −145 | −139 | −139 | −139 | −153 |
| EBIT | −212 | 662 | 1 281 | 993 | 1 122 |
| Net financials | −96 | −130 | −63 | −35 | −30 |
| Profit before tax | 27 | 405 | 941 | 764 | 842 |
| Tax | −9 | −84 | −195 | −162 | −178 |
| Net profit | 18 | 321 | 746 | 602 | 664 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 163 | 1 637 | 2 184 | 2 124 | 2 183 |
| Equity | 143 | 464 | 910 | 912 | 976 |
| Long-term debt | 433 | 547 | 318 | 247 | 0 |
| Short-term debt | 587 | 499 | 550 | 365 | 357 |
| Total debt | 1 020 | 1 046 | 868 | 612 | 357 |
EBITDA margin
18.1%
This company
15.8%
Market median
+15% vs market
20212025
Equity ratio
44.7%
This company
38.2%
Market median
+17% vs market
20212025
Return on equity
68.0%
This company
18.4%
Market median
+270% vs market
20212025
Net profit margin
9.4%
This company
8.1%
Market median
+16% vs market
20212025
Asset turnover
3.22×
This company
1.12×
Market median
+188% vs market
20212025
Debt / equity
1.24×
This company
0.62×
Market median
-100% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AK | Audit | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Artifex Sanat AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anders Kenneth Nilsson | Audit | 0 companies |
| Pär Anders Aronsson | Deputy Board Member | 0 companies |
| Nils Conny Kramer | Board of Directors | 0 companies |